Cargando…
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities
Cardiovascular disease in patients with end-stage renal disease (ESRD) is driven by a different set of processes than in the general population. These processes lead to pathological changes in cardiac structure and function that include the development of left ventricular hypertrophy and left ventri...
Autores principales: | Graham-Brown, M. P. M., Patel, A. S., Stensel, D. J., March, D. S., Marsh, A.-M., McAdam, J., McCann, G. P., Burton, J. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352874/ https://www.ncbi.nlm.nih.gov/pubmed/28349062 http://dx.doi.org/10.1155/2017/5453606 |
Ejemplares similares
-
Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance
por: Graham-Brown, M. P., et al.
Publicado: (2018) -
Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial
por: Graham-Brown, M. P. M., et al.
Publicado: (2016) -
The assessment of coronary artery disease in patients with end-stage renal disease
por: Poli, Federica E, et al.
Publicado: (2019) -
Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
por: Graham-Brown, M. P., et al.
Publicado: (2019) -
The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease
por: Adenwalla, Sherna F., et al.
Publicado: (2017)